netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Imatinib found 13 matches
Open monograph to display formulary status BNF Category
  Imatinib Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Bosutinib  (Bosulif®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Cytotoxic Drug Regorafenib  (Stivarga® ) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA209: Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (08.01.05)
link in drug section NICE TA326: Imatinib for the adjuvant treatment of gastrointestinal stromal tumours (08.01.05)
link in drug section NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA70: Guidance on the use of imatinib for chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA86: Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours (08.01.05)


 
netFormulary